Table of contents
Volume 99, Issue 6
Published online 9 September 2008 (841-988)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Genetics and Genomics |
Letters to the Editor
Minireviews
Biomarkers of apoptosis FREE
T H Ward, J Cummings, E Dean, A Greystoke, J M Hou, A Backen, M Ranson and C Dive
Br J Cancer 99: 841-846; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604519
Fusion in the ETS gene family and prostate cancer FREE
S A Narod, A Seth and R Nam
Br J Cancer 99: 847-851; doi:10.1038/sj.bjc.6604558
Clinical Studies
A randomised phase II trial of preoperative chemotherapy of cisplatin–docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) FREE
H Kunitoh, H Kato, M Tsuboi, H Asamura, H Tada, K Nagai, T Mitsudomi, T Koike, K Nakagawa, Y Ichinose, M Okada, T Shibata and N Saijo JCOG Lung Cancer Surgical Study Group, Tokyo, Japan
Br J Cancer 99: 852-857; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604613
Phase II study of short-time oxaliplatin, capecitabine and epirubicin (EXE) as first-line therapy in patients with non-resectable gastric cancer FREE
K R Schønnemann, H A Jensen, M Yilmaz, B V Jensen, O Larsen and P Pfeiffer
Br J Cancer 99: 858-861; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604569
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study FREE
T André, J M Reyes-Vidal, L Fartoux, P Ross, M Leslie, O Rosmorduc, M R Clemens, C Louvet, N Perez, F Mehmud and W Scheithauer
Br J Cancer 99: 862-867; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604628
Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer FREE
S Rao, N Starling, D Cunningham, M Benson, A Wotherspoon, C Lüpfert, R Kurek, J Oates, J Baselga and A Hill
Br J Cancer 99: 868-874; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604622
Clinician and cancer patient views on patient participation in treatment decision-making: a quantitative and qualitative exploration FREE
A H Pieterse, M C M Baas-Thijssen, C A M Marijnen and A M Stiggelbout
Br J Cancer 99: 875-882; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604611
Modelling prognostic factors in advanced pancreatic cancer FREE
D D Stocken, A B Hassan, D G Altman, L J Billingham, S R Bramhall, P J Johnson and N Freemantle
Br J Cancer 99: 883-893; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604568
Estimation of renal function and its potential impact on carboplatin dosing in children with cancer FREE
G Chinnaswamy, M Cole, A V Boddy, M Keir, L Price, A Parry, M English and G J Veal on behalf of the CCLG Pharmacology and Chemotherapy Standardisation Working Groups
Br J Cancer 99: 894-899; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604612
Translational Therapeutics
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy FREE
T Lammers, V Subr, P Peschke, R Kühnlein, W E Hennink, K Ulbrich, F Kiessling, M Heilmann, J Debus, P E Huber and G Storm
Br J Cancer 99: 900-910; advance online publication, September 2, 2008; doi:10.1038/sj.bjc.6604561
Dual MET–EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer FREE
Z Tang, R Du, S Jiang, C Wu, D S Barkauskas, J Richey, J Molter, M Lam, C Flask, S Gerson, A Dowlati, L Liu, Z Lee, B Halmos, Y Wang, J A Kern and P C Ma
Br J Cancer 99: 911-922; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604559
Molecular Diagnostics
Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC FREE
A Kalikaki, A Koutsopoulos, M Trypaki, J Souglakos, E Stathopoulos, V Georgoulias, D Mavroudis and A Voutsina
Br J Cancer 99: 923-929; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604629
Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients FREE
J Panse, K Friedrichs, A Marx, Y Hildebrandt, T Luetkens, K Bartels, C Horn, T Stahl, Y Cao, K Milde-Langosch, A Niendorf, N Kröger, S Wenzel, R Leuwer, C Bokemeyer, S Hegewisch-Becker and D Atanackovic
Br J Cancer 99: 930-938; doi:10.1038/sj.bjc.6604621
GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics FREE
G Kristiansen, F R Fritzsche, K Wassermann, C Jäger, A Tölle, M Lein, C Stephan, K Jung, C Pilarsky, M Dietel and H Moch
Br J Cancer 99: 939-948; doi:10.1038/sj.bjc.6604614
Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer FREE
S Senapati, P Chaturvedi, P Sharma, G Venkatraman, J L Meza, W El-Rifai, H K Roy and S K Batra
Br J Cancer 99: 949-956; doi:10.1038/sj.bjc.6604632
Smad7 induces hepatic metastasis in colorectal cancer FREE
S K Halder, G Rachakonda, N G Deane and P K Datta
Br J Cancer 99: 957-965; advance online publication, August 19, 2008; doi:10.1038/sj.bjc.6604562
Genetics and Genomics
Reduced expression of a gene proliferation signature is associated with enhanced malignancy in colon cancer FREE
A Anjomshoaa, Y-H Lin, M A Black, J L McCall, B Humar, S Song, R Fukuzawa, H-S Yoon, B Holzmann, J Friederichs, A van Rij, M Thompson-Fawcett and A E Reeve
Br J Cancer 99: 966-973; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604560
An evaluation of the polymorphisms Ins16bp and Arg72Pro in p53 as breast cancer risk modifiers in BRCA1 and BRCA2 mutation carriers FREE
A Osorio, M Pollán, G Pita, R K Schmutzler, B Versmold, C Engel, A Meindl, N Arnold, S Preisler-Adams, D Niederacher, W Hofmann, D Gadzicki, A Jakubowska, U Hamann, J Lubinski, A Toloczko-Grabarek, C Cybulski, T Debniak, G Llort, D Yannoukakos, O Díez, B Peissel, P Peterlongo, P Radice, T Heikkinen, H Nevanlinna, P L Mai, J T Loud, L McGuffog, A C Antoniou and J Benitez on behalf of CIMBA
Br J Cancer 99: 974-977; doi:10.1038/sj.bjc.6604624
Genetic regulation of MUC1 alternative splicing in human tissues FREE
W Ng, A X W Loh, A S Teixeira, S P Pereira and D M Swallow
Br J Cancer 99: 978-985; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604617
Letters to the Editor
Early onset of breast cancer in Black British women: how reliable are the findings? FREE
J D Ingleby
Br J Cancer 99: 986-987; doi:10.1038/sj.bjc.6604625
Reply: Early onset of breast cancer in black British women: how reliable are the findings? FREE
S W Duffy, R L Bowen, D A Ryan, I R Hart and J L Jones
Br J Cancer 99: 988; advance online publication, August 26, 2008; doi:10.1038/sj.bjc.6604626
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
